193 related articles for article (PubMed ID: 21257891)
1. Imaging findings after radiofrequency ablation of adrenal tumors.
Brook OR; Mendiratta-Lala M; Brennan D; Siewert B; Faintuch S; Goldberg SN
AJR Am J Roentgenol; 2011 Feb; 196(2):382-8. PubMed ID: 21257891
[TBL] [Abstract][Full Text] [Related]
2. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Mayo-Smith WW; Dupuy DE
Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
[TBL] [Abstract][Full Text] [Related]
3. Fatty hepatocellular carcinoma: radiofrequency ablation--imaging findings.
Pupulim LF; Hakimé A; Barrau V; Abdel-Rehim M; Zappa M; Vilgrain V
Radiology; 2009 Mar; 250(3):940-8. PubMed ID: 19164699
[TBL] [Abstract][Full Text] [Related]
4. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
5. Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
Hasegawa T; Yamakado K; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Miki M; Sasaki T; Sakuma H; Sugimura Y
Radiology; 2015 Nov; 277(2):584-93. PubMed ID: 25997031
[TBL] [Abstract][Full Text] [Related]
6. Imaging-guided percutaneous radiofrequency ablation of adrenal metastases: preliminary results at a single institution with a single device.
Carrafiello G; Laganà D; Recaldini C; Giorgianni A; Ianniello A; Lumia D; D'Ambrosio A; Petullà M; Dionigi G; Fugazzola C
Cardiovasc Intervent Radiol; 2008; 31(4):762-7. PubMed ID: 18421499
[TBL] [Abstract][Full Text] [Related]
7. Adrenal neoplasms: Effectiveness and safety of CT-guided ablation of 23 tumors in 22 patients.
Wolf FJ; Dupuy DE; Machan JT; Mayo-Smith WW
Eur J Radiol; 2012 Aug; 81(8):1717-23. PubMed ID: 21636231
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of radiofrequency ablation in the treatment of small functional adrenal neoplasms.
Mendiratta-Lala M; Brennan DD; Brook OR; Faintuch S; Mowschenson PM; Sheiman RG; Goldberg SN
Radiology; 2011 Jan; 258(1):308-16. PubMed ID: 20980448
[TBL] [Abstract][Full Text] [Related]
9. Catecholamine Surge during Image-Guided Ablation of Adrenal Gland Metastases: Predictors, Consequences, and Recommendations for Management.
Fintelmann FJ; Tuncali K; Puchner S; Gervais DA; Thabet A; Shyn PB; Arellano RS; Tatli S; Mueller PR; Silverman SG; Uppot RN
J Vasc Interv Radiol; 2016 Mar; 27(3):395-402. PubMed ID: 26724964
[TBL] [Abstract][Full Text] [Related]
10. A single-institution experience in image-guided thermal ablation of adrenal gland metastases.
Welch BT; Callstrom MR; Carpenter PC; Wass CT; Welch TL; Boorjian SA; Nichols DA; Thompson GB; Lohse CM; Erickson D; Leibovich BC; Atwell TD
J Vasc Interv Radiol; 2014 Apr; 25(4):593-8. PubMed ID: 24507995
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of CT-guided percutaneous radiofrequency ablation of adrenal metastases.
Zhou K; Pan J; Yang N; Shi HF; Cao J; Li YM; Zhang HZ; Wang KF; Chen SH
Br J Radiol; 2018 May; 91(1085):20170607. PubMed ID: 29350539
[TBL] [Abstract][Full Text] [Related]
12. Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience.
Botsa EI; Thanou IL; Papatheodoropoulou AT; Thanos LI
Chin Med J (Engl); 2017 Sep; 130(17):2027-2032. PubMed ID: 28707652
[TBL] [Abstract][Full Text] [Related]
13. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Siegel C
J Urol; 2005 Sep; 174(3):867. PubMed ID: 16093972
[No Abstract] [Full Text] [Related]
14. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
15. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT.
Jin GY; Lee JM; Lee YC; Han YM; Lim YS
AJR Am J Roentgenol; 2004 Oct; 183(4):1013-20. PubMed ID: 15385295
[TBL] [Abstract][Full Text] [Related]
17. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of CT findings after radiofrequency ablation of hepatic tumors.
Park MH; Rhim H; Kim YS; Choi D; Lim HK; Lee WJ
Radiographics; 2008; 28(2):379-90; discussion 390-2. PubMed ID: 18349446
[TBL] [Abstract][Full Text] [Related]
20. Adrenal masses: CT characterization with histogram analysis method.
Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
